Ghost Tree Capital, LLC
- SEC CIK
- 0001595851
- Latest filing
- Nov 14, 2024
SYRE holding history
Spyre Therapeutics, Inc. in every 13F filed by Ghost Tree Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SYRE overviewAll 13F holders of SYREFull Q3 2024 holdings
- Shares (Q3 2024)
- 60,000
- Value
- $1.76M
- % of portfolio
- 0.6%
- Quarters held
- 7
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 60,000 | $1.76M | 0.6% | −190,237−76.0% | Reduced | Holders |
| Q2 2024 | 250,237 | $5.88M | 2.0% | +150,237+150.2% | Added | Holders |
| Q1 2024 | 100,000 | $3.79M | 1.2% | +100,000 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −800,000−100.0% | Sold out | Holders |
| Q4 2022 | 800,000 | $360.0K | 0.2% | −200,000−20.0% | Reduced | Holders |
| Q3 2022 | 1,000,000 | $526.0K | 0.2% | +75,000+8.1% | Added | Holders |
| Q2 2022 | 925,000 | $467.0K | 0.3% | +238,401+34.7% | Added | Holders |
| Q1 2022 | 686,599 | $1.58M | 0.8% | +686,599 | New | Holders |